Oxymorphone Hydrochloride Tablet
Product Images NDC 13107-103

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Oxymorphone Hydrochloride (NDC 13107-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Oxymorphone Str)

Chemical structure of Oxymorphone Hydrochloride showing its molecular arrangement with hydroxyl groups, ketone groups, and the hydrochloride moiety.*

FDA Label Image

Oxymorphonehcl10mg

Oxymorphone Hydrochloride Tablets 10 mg oral tablets packaging label. The label indicates the product contains 100 tablets and is distributed by Aurobindo Pharma USA LLC, Dayton, NJ. The label includes storage instructions and a note to see package insert for full prescribing information. NDC 13107-104-01 is visible.*

FDA Label Image

Oxymorphonehcl5mg

Oxymorphone Hydrochloride Tablets 5 mg label for oral use, distributed by Aurobindo Pharma USA LLC, Dayton, NJ. The label includes NDC 13107-103-01, a quantity of 100 tablets, and storage instructions between 20° to 25°C. The label also references child-resistant packaging and prescribing information details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.